{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:39:04Z","timestamp":1793813944837,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bladder cancer remains one of the most prevalent causes of cancer-related mortality worldwide. Mumio, a naturally occurring substance with a long-standing history of use in traditional medicine, has demonstrated therapeutic potential, including anticancer properties. This study aimed to evaluate the effects of a pharmaceutical formulation of Mumio on the growth of normal (SV-HUC-1) and cancerous (T24, 5637) bladder cell lines in 3D culture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Spheroids were generated using ultra-low attachment 96-well plates. Three concentrations of Mumio (LC\u2081\u2080, LC\u2085\u2080, LC\u2089\u2080), previously determined in 2D culture, were applied. Cells were incubated for 24, 48, and 72\u00a0h. Cell viability and caspase activity in 3D culture were assessed via luminescence-based assays. Hematoxylin\u2013eosin (HE) and Ki-67 staining were performed to evaluate spheroid morphology and proliferation. Gene expression analysis was conducted to investigate molecular mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mumio exhibited dose-dependent cytotoxicity in 3D culture, with T24 cells showing the highest sensitivity compared to the control and the second bladder cancer cell line (5637) after all incubation times. Concentrations effective in 2D culture were less potent in 3D conditions. Proliferation rates decreased with increasing Mumio concentration and prolonged exposure. Molecular analysis revealed G1 phase cell cycle arrest and reduced DNA synthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mumio has potential in supportive bladder cancer treatment; however, its effectiveness, as observed in 2D culture, exhibited diminished efficacy when applied to 3D cultures. Further investigations are necessary, including the use of organoids or animal models, to confirm these properties.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15838-1","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:45:57Z","timestamp":1773456357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mumio and bladder cancer: unlocking its potential in 3D cell culture"],"prefix":"10.1186","volume":"26","author":[{"given":"Zuzanna","family":"Fekner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sieracka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"D\u0105browski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Ka\u017amierski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rasmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Jundzi\u0142\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Drewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Grzanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pokrywczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Kloskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"15838_CR1","doi-asserted-by":"crossref","unstructured":"Kloskowski T, Szeliski K, Krzeszowiak K, Fekner Z, Kazimierski \u0141, Jundzi\u0142\u0142 A, et al. Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment. Sci Rep . 2021;11(1):22614. Available from: https:\/\/www.nature.com\/articles\/s41598-021-01996-8","DOI":"10.1038\/s41598-021-01996-8"},{"key":"15838_CR2","doi-asserted-by":"crossref","unstructured":"Stohs SJ. Safety and Efficacy of Shilajit (Mumie, Moomiyo). Phyther Res . 2014;28(4):475\u20139. Available from:\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ptr.5018.","DOI":"10.1002\/ptr.5018"},{"key":"15838_CR3","doi-asserted-by":"crossref","unstructured":"Pandit S, Biswas S, Jana U, De RK, Mukhopadhyay SC, Biswas TK. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia . 2016;48(5):570\u20135. Available from:\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/and.12482.","DOI":"10.1111\/and.12482"},{"key":"15838_CR4","doi-asserted-by":"crossref","unstructured":"Ding R, Zhao M, Fan J, Hu X, Wang M, Zhong S, et al. Mechanisms of generation and exudation of Tibetan medicine Shilajit (Zhaxun). Chin Med . 2020;15(1):65. Available from:\u00a0https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-020-00343-9.","DOI":"10.1186\/s13020-020-00343-9"},{"key":"15838_CR5","doi-asserted-by":"crossref","unstructured":"Rahmani Barouji S, Saber A, Torbati M, Fazljou SMB, Yari Khosroushahi A. Health Beneficial Effects of Moomiaii in Traditional Medicine. Galen Med J . 2020;9:e1743. Available from: https:\/\/www.gmj.ir\/index.php\/gmj\/article\/view\/1743","DOI":"10.31661\/gmj.v9i0.1743"},{"key":"15838_CR6","unstructured":"Aladi PC, Vikhe SR. Shilajit: a Wonder Drug of Ayurveda. Certif J \u2502 Aladi al World J Pharm Med Res . 2022;8(1):1\u201323. Available from: www.wjpmr.com"},{"key":"15838_CR7","doi-asserted-by":"crossref","unstructured":"Aiello A, Fattorusso E, Menna M, Vitalone R, Schr\u00f6der HC, M\u00fcller WEG. Mumijo Traditional Medicine: Fossil Deposits from Antarctica (Chemical Composition and Beneficial Bioactivity). Evidence-Based Complement Altern Med . 2011;2011(1). Available from:\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/10.1093\/ecam\/nen072.","DOI":"10.1093\/ecam\/nen072"},{"key":"15838_CR8","doi-asserted-by":"crossref","unstructured":"Mishra RK, Jain A, Singh SK. Profertility effects of Shilajit on cadmium-induced infertility in male mice. Andrologia . 2018;50(8):e13064. Available from:\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/and.13064.","DOI":"10.1111\/and.13064"},{"key":"15838_CR9","doi-asserted-by":"crossref","unstructured":"Kangari P, Roshangar L, Iraji A, Talaei-Khozani T, Razmkhah M. Accelerating effect of Shilajit on osteogenic property of adipose-derived mesenchymal stem cells (ASCs). J Orthop Surg Res . 2022;17(1):424. Available from:\u00a0https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-022-03305-z.","DOI":"10.1186\/s13018-022-03305-z"},{"key":"15838_CR10","doi-asserted-by":"crossref","unstructured":"Bhavsar SK, Thaker AM, Malik JK. Shilajit. In: Nutraceuticals . Elsevier; 2016. p. 707\u201316. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128021477000516","DOI":"10.1016\/B978-0-12-802147-7.00051-6"},{"key":"15838_CR11","doi-asserted-by":"crossref","unstructured":"Carrasco-Gallardo C, Guzm\u00e1n L, Maccioni RB. Shilajit\u202f: A Natural Phytocomplex with Potential Procognitive Activity. Int J Alzheimers Dis . 2012;2012:1\u20134. Available from: http:\/\/www.hindawi.com\/journals\/ijad\/2012\/674142\/","DOI":"10.1155\/2012\/674142"},{"key":"15838_CR12","doi-asserted-by":"crossref","unstructured":"Elahi S, Mohamadi Sani A, Sarabi-Jamab M. Physicochemical, antioxidant and antimicrobial characteristics of two types of mumies(shilajit). J Food Meas Charact . 2024;18(6):4137\u201346. Available from:\u00a0https:\/\/link.springer.com\/10.1007\/s11694-024-02481-2.","DOI":"10.1007\/s11694-024-02481-2"},{"key":"15838_CR13","doi-asserted-by":"crossref","unstructured":"Kangari P, Roshangar L, Tanideh N, Afshari F, Chenari N, Talaei-Khozani T, et al. Shilajit Boosts Osteogenic Ability of Mesenchymal Stem Cells for Regeneration of Rat Bone Defect. Regen Eng Transl Med . 2024;10(2):284\u201393. Available from:\u00a0https:\/\/link.springer.com\/10.1007\/s40883-023-00329-7.","DOI":"10.1007\/s40883-023-00329-7"},{"key":"15838_CR14","doi-asserted-by":"crossref","unstructured":"Pavithra R, Khan MR, Khan MS. Recent advancements in natural compounds for cancer therapy and prevention. Phytochem Rev . 2024;23(6):1835\u201359. Available from:\u00a0https:\/\/link.springer.com\/10.1007\/s11101-024-09940-0.","DOI":"10.1007\/s11101-024-09940-0"},{"key":"15838_CR15","doi-asserted-by":"crossref","unstructured":"Velmurugan C, Vivek B, Wilson E, Bharathi T, Sundaram T. Evaluation of safety profile of black shilajit after 91 days repeated administration in rats. Asian Pac J Trop Biomed . 2012;2(3):210\u20134. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2221169112600434","DOI":"10.1016\/S2221-1691(12)60043-4"},{"key":"15838_CR16","doi-asserted-by":"crossref","unstructured":"Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: a review. Phyther Res . 2007;21(5):401\u20135. Available from:\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ptr.2100.","DOI":"10.1002\/ptr.2100"},{"key":"15838_CR17","doi-asserted-by":"crossref","unstructured":"Keller JL, Housh TJ, Hill EC, Smith CM, Schmidt RJ, Johnson GO. The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels. J Int Soc Sports Nutr . 2019;16(1). Available from:\u00a0https:\/\/www.tandfonline.com\/doi\/full\/10.1186\/s12970-019-0270-2.","DOI":"10.1186\/s12970-019-0270-2"},{"key":"15838_CR18","doi-asserted-by":"crossref","unstructured":"Sadeghi SMH, Hosseini Khameneh SM, Khodadoost M, Hosseini Kasnavieh SM, Kamalinejad M, Gachkar L, et al. Efficacy of Momiai in Tibia Fracture Repair: A Randomized Double-Blinded Placebo-Controlled Clinical Trial. J Altern Complement Med . 2020;26(6):521\u20138. Available from:\u00a0https:\/\/www.liebertpub.com\/doi\/10.1089\/acm.2019.0453.","DOI":"10.1089\/acm.2019.0453"},{"key":"15838_CR19","doi-asserted-by":"crossref","unstructured":"Rahmani Barouji S, Shahabi A, Torbati M, Fazljou SMB, Yari Khosroushahi A. Mummy Induces Apoptosis Through Inhibiting of Epithelial-Mesenchymal Transition (EMT) in Human Breast Cancer Cells. Galen Med J . 2020;9:e1812. Available from: https:\/\/www.gmj.ir\/index.php\/gmj\/article\/view\/1812","DOI":"10.31661\/gmj.v9i0.1812"},{"key":"15838_CR20","doi-asserted-by":"crossref","unstructured":"Kordestani Z, Melki E, Vahidi R, Shideh R, Ghorbani N, Yazdi Rouholamini SE, et al. Modulation of IKK\/NF-\u03baB Signaling: A Therapeutic Mechanism of Shilajit in Breast Cancer Cells. J Kerman Univ Med Sci . 2024;31(2):66\u201371. Available from: https:\/\/jkmu.kmu.ac.ir\/article_92278.html","DOI":"10.34172\/jkmu.2024.12"},{"key":"15838_CR21","doi-asserted-by":"crossref","unstructured":"Hussain A, Saeed A. Hazardous or Advantageous: Uncovering the Roles of Heavy Metals and Humic Substances in Shilajit (Phyto-mineral) with Emphasis on Heavy Metals Toxicity and Their Detoxification Mechanisms. Biol Trace Elem Res . 2024;202(12):5794\u2013814. Available from:\u00a0https:\/\/link.springer.com\/10.1007\/s12011-024-04109-4.","DOI":"10.1007\/s12011-024-04109-4"},{"issue":"4","key":"15838_CR22","first-page":"910","volume":"14","author":"M Kapa\u0142czy\u0144ska","year":"2018","unstructured":"Kapa\u0142czy\u0144ska M, Kolenda T, Przyby\u0142a W, Zaj\u0105czkowska M, Teresiak A, Filas V, et al. 2D and 3D cell cultures \u2013 a comparison of different types of cancer cell cultures. Arch Med Sci. 2018;14(4):910\u20139.","journal-title":"Arch Med Sci"},{"key":"15838_CR23","doi-asserted-by":"crossref","unstructured":"Zuiverloon TCM, de Jong FC, Costello JC, Theodorescu D. Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines. Bl Cancer . 2018;4(2):169\u201383. Available from:\u00a0https:\/\/journals.sagepub.com\/doi\/10.3233\/BLC-180167.","DOI":"10.3233\/BLC-180167"},{"key":"15838_CR24","doi-asserted-by":"crossref","unstructured":"Nickerson ML, Witte N, Im KM, Turan S, Owens C, Misner K, et al. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response. Oncogene . 2017;36(1):35\u201346. Available from: https:\/\/www.nature.com\/articles\/onc2016172","DOI":"10.1038\/onc.2016.172"},{"issue":"2","key":"15838_CR25","first-page":"7","volume":"2","author":"T Phaechamud","year":"2008","unstructured":"Phaechamud T, Juree C, Penpun W, St LC. Some biological activities and safety of mineral pitch. Sci Eng Health Stud. 2008;2(2):7\u201317.","journal-title":"Sci Eng Health Stud"},{"key":"15838_CR26","doi-asserted-by":"crossref","unstructured":"Asadi Z, Jalilian S, Arkan E, Aghaz F. How Shilajit-Based Nanocarriers Alter Classical Doxorubicin Delivery to Breast Cancer Cells (MCF-7 and ZR-75\u20131). ACS Med Chem Lett . 2024;15(4):449\u201356. Available from:\u00a0https:\/\/pubs.acs.org\/doi\/10.1021\/acsmedchemlett.3c00538.","DOI":"10.1021\/acsmedchemlett.3c00538"},{"key":"15838_CR27","doi-asserted-by":"crossref","unstructured":"Jambi EJ, Abdulaziz Alshubaily F. Shilajit potentiates the effect of chemotherapeutic drugs and mitigates metastasis induced liver and kidney damages in osteosarcoma rats. Saudi J Biol Sci . 2022;29(9):103393. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319562X22003096","DOI":"10.1016\/j.sjbs.2022.103393"},{"key":"15838_CR28","doi-asserted-by":"crossref","unstructured":"Tavassoli Azin MM. The Anti-Cancer Property of Mumie as Natural Product on Human Cervical Cancer Cell Line (HeLa). J Environ Treat Tech . 2020;9(1):196\u2013202. Available from: http:\/\/www.jett.dormaj.com\/docs\/Volume9\/Issue 1\/The Anti-Cancer Property of Mumie as Natural Product on Human Cervical Cancer Cell Line (HeLa).pdf","DOI":"10.47277\/JETT\/9(1)202"},{"key":"15838_CR29","doi-asserted-by":"crossref","unstructured":"Pant K, Gupta P, Damania P, Yadav AK, Gupta A, Ashraf A, et al. Mineral pitch induces apoptosis and inhibits proliferation via modulating reactive oxygen species in hepatic cancer cells. BMC Complement Altern Med . 2016;16:148. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27233240","DOI":"10.1186\/s12906-016-1131-z"},{"key":"15838_CR30","doi-asserted-by":"crossref","unstructured":"Alqarni A, Hosmani J, Mohammed R, Alqahtani A, Alasiri S, Alhamid N, et al. Shilajit (Mumio) Elicits Apoptosis and Suppresses Cell Migration in Oral Cancer Cells through Targeting Urokinase-type Plasminogen Activator and Its Receptor and Chemokine Signaling Pathways. Pharmacogn Mag . 2025;21(2):491\u2013506. Available from:\u00a0https:\/\/journals.sagepub.com\/doi\/10.1177\/09731296241275740.","DOI":"10.1177\/09731296241275740"},{"key":"15838_CR31","doi-asserted-by":"crossref","unstructured":"Mandraju RK, Kannapiran P, Kondapi AK. Distinct roles of Topoisomerase II isoforms: DNA damage accelerating \u03b1, double strand break repair promoting \u03b2. Arch Biochem Biophys. 2008;470(1):27\u201334. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986107005243","DOI":"10.1016\/j.abb.2007.10.017"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15838-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:03:54Z","timestamp":1781640234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15838-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15838"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15838-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"510"}}